Summary
Psoriasis is a common chronic skin disease with strong genetic associations and environmental triggers. Patients with psoriasis develop sore throats much more frequently than nonpsoriatic individuals and it is well documented that streptococcal throat infections can trigger the onset of psoriasis, and such infections cause exacerbation of chronic psoriasis. It is now generally accepted that psoriatic lesions are caused by abnormal reactivity of specific T lymphocytes in the skin. However, it has been shown in recent years that activation of specific immunity is always preceded by activation of nonspecific innate immune mechanisms, and that abnormalities in the innate immune system can cause dysregulation in specific immune responses. Here we explore the possible immune mechanisms that are involved in the link between infection of the tonsils and this inflammatory skin disease. Moreover, we survey the literature and discuss the suitability of tonsillectomy as a treatment for psoriasis.
Psoriasis, a T-cell-mediated autoimmune disease
Psoriasis is a common chronic inflammatory skin disease, most often characterized by thickened erythematous scaly plaques, and appears in a variety of forms with distinct characteristics. The most common form, psoriasis vulgaris, affects 1-3% of the Caucasian population, 1 usually persists -with 40% developing seronegative arthritis -and has a very negative impact on quality of life. 2 Psoriasis is generally regarded as a T-cellmediated autoimmune disease, [3] [4] [5] The palatine tonsils might play a major role in psoriasis as they are a common site for streptococcal infections and, as immune sentries loaded with antigen-presenting cells and T cells, are likely a major site for T-cell priming against such antigens. Here we detail how the immune function of the tonsils could lead to the initiation and exacerbation of psoriasis and we survey potential interventions.
The tonsils, immunological sentries of the pharynx
The mucosal surfaces of the mouth, throat and upper respiratory tract are the first major barrier protecting the host from potentially invading microorganisms, and integral to this defence are the tonsils, which provide a protective immunological ring (Waldeyer's ring) at the openings of both the digestive and respiratory tracts. 14 The palatine tonsils have a surface lined by a stratified squamous epithelium that extends into deep and branched crypts, increasing their total surface area. The surface of the crypts is lined with a reticulated epithelium, which in parts may be only one cell thick. The reticulated tonsil epithelium has a unique cellular composition where epithelial cells, stromal cells, intraepithelial lymphocytes, dendritic cells (DCs), neutrophils and macrophages are all situated in close proximity, which is ideal for productive antigen sampling. In the subepithelial space are B-cell-rich lymphoid follicles that foster the development of memory B cells and antibody producing plasma cells, a process that requires the interaction of a number of B-cell, T-cell and DC subsets. 15 Six phenotypes of DC have been identified in the tonsils, 16, 17 each with a different location and function. DCs are particularly adept at antigen sampling and processing and presentation of peptide antigens, and influence the T helper 1 (Th1) ⁄Th2 ⁄Th17 balance of T-cell-mediated responses. 18 The involvement of streptococci in psoriasis
The most frequent tonsil diseases are recurrent infections and abnormal enlargement of the tonsils (hypertrophy), which may result in the need for tonsillectomy. Streptococcus pyogenes infections are associated with acute and recurrent throat infections, 19, 20 while Haemophilus influenzae infections are thought to stimulate hypertrophic responses. 21 Throat infection with b-haemolytic streptococci is the only well-defined external trigger that has been convincingly associated with initiation and acute exacerbation of psoriasis. [22] [23] [24] [25] [26] This association was corroborated in a prospective study that concluded that patients with psoriasis reported a sore throat 10 times more often than household controls, and that streptococcal throat infections can cause exacerbation of chronic plaque psoriasis. 24 Furthermore, a-streptococci are likely to have a role in pustulosis palmaris et plantaris (PPP), a chronic, recurrent, inflammatory skin disease restricted to the palms and soles. 27 These two inflammatory skin diseases appear to benefit from tonsillectomy, [28] [29] [30] suggesting the importance of the palatine tonsils in inflammatory diseases outside the throat. Tonsils from individuals with PPP differ from recurrently infected tonsils with regard to histology and the expression of skin homing molecules by T cells. Furthermore, the size of the T-cell area in tonsils has been associated with skin improvement after tonsillectomy. 30 In this respect, we have recently demonstrated that, compared with nonpsoriatic individuals, tonsils from patients with psoriasis contain an increased frequency of T cells with skin homing potential (Sigurdardottir, manuscript in preparation). Moreover, superantigens from b-haemolytic streptococci have been demonstrated to enhance T-cell expression of cutaneous lymphocyte-associated antigen (CLA), 31 ,32 a carbohydrate moiety expressed on 80% of T cells in the skin, 33 and the frequency of CLA+CD8+ T cells in the blood of patients with psoriasis correlates with their disease severity. 34 The importance of specific effector ⁄memory T cells is now generally recognized in psoriasis, 4 but it remains to be elucidated why and where the effector T cells are activated. In this regard, the innate immune response of the tonsils may play a crucial role in the instigation and subsequent regulation of the T-cell-mediated adaptive immune response. Thus, aberrant tonsil responses to streptococcal infection could lead to altered T-cell expansion and trafficking to the skin where they induce an inflammatory response that initiates the psoriasis plaque. This is further supported by the fact that similar oligoclonal T cells have been isolated from tonsils and psoriatic plaques of the same individual, 35 with disease remission following tonsillectomy. 35 The potential of tonsillectomy for the treatment of psoriasis ). A search of the PubMed database using the search terms 'psoriasis', 'tonsils' and 'tonsillectomy' revealed 71 articles from 1960 to 2012. After limiting our search to those studies on 'chronic plaque psoriasis' or 'guttate psoriasis' or 'psoriasis vulgaris', excluding 'palmoplantar pustulosis' or 'pustulosis palmaris et plantaris', and following up citations within these publications, we noted that there exist 12 original case reports or studies on the effect of tonsillectomy on psoriasis (Table 1 ). In the first report, Whyte and Baughman 46 described the improvement of psoriasis and decrease in antistreptolysin O titres following tonsillectomy of three patients with guttate psoriasis. This was followed by the first controlled trial, a 1967 report from Germany 47 that described 92 patients with psoriasis with chronic tonsillitis, of whom 56 underwent tonsillectomy whereupon 34 (61%) improved and 22 (39%) appeared unchanged. This compares with the control group of 36 patients with psoriasis who did not have a tonsillectomy, of whom 8 (22%) improved and 28 (78%) were unchanged. The authors did not give details of whether the control group was matched for age and sex, nor did they use a quantitative scoring system for disease severity. Later, Nyfors et al. 48 conducted an uncontrolled retrospective study, which examined the effect of tonsillectomy on 74 young (mean age 14AE2 years) patients with psoriasis vulgaris that proved to be refractory to topical treatments. During the follow-up period (mean 4AE5 years), 32% of patients remained clear of psoriasis, 39% had a considerable improvement, 22% were unchanged and 7% worsened. Another case report 49 describes the effect of tonsillectomy on two young sisters with guttate psoriasis that developed 1 week after catching a cold and severe sore throat. Interestingly, both sisters carried the human leucocyte antigen-B37 allele, which is part of one of the psoriasis risk haplotypes. 50 In both cases the skin lesions cleared almost completely within 2 months of tonsillectomy; however, the treatment was complicated by the postoperative use of antibiotics and topical corticosteroid cream. Over 10 years later, Hone et al. 51 reported an uncontrolled prospective study on 13 patients (mean age 17 years) with recalcitrant psoriasis. The group consisted of six patients with guttate psoriasis and seven with chronic plaque psoriasis. From the group as a whole, seven patients showed complete clearance and three showed significantly improved psoriasis following tonsillectomy, with noticeable improvement within a month. The data for the patients with guttate psoriasis was more impressive, as the disease cleared in five out of six patients, with the remaining patient having a significant improvement. The authors claim that the patients served as their own controls, yet they omitted to acknowledge that patients with guttate psoriasis might have spontaneous remissions. In the same year, a Japanese study including 35 patients with psoriasis vulgaris 52 reported that 49% of the patients showed a clear improvement in their clinical symptoms following tonsillectomy, which was more effective for women (84% having some degree of improvement) than men (31%). It was also more effective in younger patients: 83% of those under the age of 20 years showed some degree of improvement, which fell to 68% in the under-30s category. In 1998, Rosenberg et al. 53 reported clearance of psoriasis in nine of 14 patients following tonsillectomy, and a significant improvement in the remaining five. All 14 patients had evidence of streptococcal colonization that could not be resolved by antibiotics. A year later, McMillin et al. 54 gave details of two case reports. The first was a 5-year-old girl who had severe early-onset psoriasis, a history of enlarged tonsils and one episode of streptococcal pharyngitis. The second was an 11-year-old boy with early-onset guttate psoriasis and recurrent streptococcal pharyngitis. As with the earlier report from Hone et al., 51 the children showed a marked improvement in their psoriasis as early as 1 month after adenotonsillectomy and both were clear of psoriasis at a 16-month follow-up examination. In the same year, Ozawa et al. 55 conducted a multicentre retrospective study based on physician questionnaires, which included 385 cases of generalized pustular psoriasis. They reported that tonsillectomy was 'effective' for 16AE7% of the patients. A more recent report came from Japan in 2001, where seven patients with psoriasis underwent tonsillectomy and were followed up for 2-9 years after surgery. 56 All lesions had cleared in three patients and 80% of lesions cleared in two patients, with no changes in the disease of the remaining two. Of the five patients showing improvement, four had a history of tonsillitis making their skin lesions worse. The group of Prinz followed three patients with recalcitrant chronic plaque psoriasis with guttate flares for 3 years after tonsillectomy and reported complete remission. 35 Moreover, analysis of T-cell receptor beta-chain variable region gene rearrangements suggested that T cells from the same T-cell clones were simultaneously present within the skin and tonsils of these patients. 35 These data are compelling but case reports carry limitations inherent in their study design (or lack thereof), given that the patients are managed in a noncontrolled environment, the observation is based on an individual or small group, which may not reflect a larger population, and some of the effects noted may have simply arisen from the natural history of the disease, rather than the treatment. Thus, we recently completed a prospective, controlled, observer-blinded trial 29 involving 29 patients with chronic psoriasis and a history of exacerbation after sore throat, who were randomly assigned to tonsillectomy (n = 15) or control (n = 14) groups and were followed for 2 years. Of this group, 13 patients (86%) showed sustained improvement after tonsillectomy ranging from 30% to 90% reduction in disease severity. In addition to clinical follow-up, we assessed blood T cell responses to pools of short peptides derived from human epidermal keratins and streptococcal M proteins, and found a close correlation between the degree of clinical improvement in individual patients and reduction in the frequency of peptide-reactive skin-homing T cells in the blood. 29 No corresponding clinical or immunological changes were observed among the control group.
Outlook
All of the studies and case reports reviewed here conclude that tonsillectomy may be of considerable benefit to selected patients. Psoriasis is influenced by multiple genetic polymorphisms and environmental factors, 57 resulting in a range of disease severity and course among patients, which is likely reflected in the response to treatment. 58, 59 Some patients with recalcitrant guttate or chronic plaque psoriasis, particularly those with early-onset psoriasis that is exacerbated by streptococcal tonsillitis, appear to have long-term remissions following tonsillectomy. In our recent study, 29 tonsillectomized patients not only benefited in terms of reduction of skin lesions but they also required less symptomatic treatment than the control patients, indicating that longer-term follow-up studies should also focus on that issue. Thus, in some cases, tonsillectomy could become an adjunct to existing therapy, to reduce the dosage of drugs or allow the use of a less potent drug to control the disease. This becomes an interesting consideration in our era of expensive biological treatments. However, it remains to be seen how effective tonsillectomy is in the long term and exactly which patent groups will gain the most benefit.
What's already known about this topic?
• There is a well-established association between streptococcal tonsillitis and psoriasis, yet studies on the efficacy of tonsillectomy for psoriasis have never been afforded mainstream attention.
What does this study add?
• We have reviewed tonsil immunology and how tonsil infection could lead to skin disease.
• We have also reviewed all available reports of the outcome of tonsillectomy on psoriasis, including a recent observer-blinded prospective study, and identified patients who may potentially benefit from this procedure.
